a trend toward significancep = 0.078
As shown in Table 2 , female gender demonstrated a trend toward significance (10/15, 66.7% vs. 177/312, 56.7%; p = 0.078).
As shown in Table 2 , female gender demonstrated a trend toward significance (10/15, 66.7% vs. 177/312, 56.7%; p = 0.078).
The analysis revealed that while age, gender, and family history were not statistically significant predictors, a higher educational level (university degree or above) showed a notable trend toward a lower likelihood of reporting psychological barriers (OR: 0.56, 95% CI: 0.30-1.06, p = 0.078).
Multivariable regression indicated that higher educational attainment showed a trend toward a lower likelihood of reporting psychological barriers (OR: 0.56, p = 0.078).
Although not statistically significant, female patients showed a trend toward longer hospitalization (β = 12.14 days, p = 0.078), which may warrant further investigation.
Gestational age ≥37 weeks showed borderline significance (aOR: 1.32, 95% CI: 0.97-1.80, p=0.078).
TAPSE/PASP <0.32 showed a numerical trend toward higher mortality compared to the normal ratio (32.1% vs. 15.8%, p=0.0785), but this was not statistically significant, while moderate impairment (0.32-0.419) was comparable to normal level (18.9% vs. 15.8%, p=0.7727).
The DTB parameter was almost significant with P = 0.079.
Time from last fraction of brachytherapy to date of neck dissection showed a trend toward statistical significance (HR: 0.907, 95% CI: 0.814-1.011, p=0.079).
In contrast, participants treated with placebo+SOC showed an increase in uACR by 159.55% (99.88 μg/mg) with p-value approaching significance (p=0.079), again emphasizing the beneficial outcome when NAC+taurine was supplemented to SOC (Table 2 , Figure 2 ).
Gender also approached significance (p=0.079), with higher failure observed in males (10.3%) relative to females (5.0%).
Although not statistically significant, neonates born via caesarean section showed a trend toward delayed oxygenation compared with those delivered vaginally, with mean pre-ductal times of 9.05 vs. 8.41 minutes, respectively (p = 0.079).
As displayed in Table 2 , compared to those with their disease in remission, patients with ongoing active disease (progressors) had significantly more stress (p<0.001), low education status (borderline significance of p=0.08), significantly worse functional capacity as per HAQ scores (p<0.001), and more hematological and renal involvements (p<0.001).
In terms of safety, ADCs showed a trend toward fewer grade ≥3 Aes (OR = 0.68, p = 0.08), supporting their improved tolerability compared with conventional chemotherapy, and Diéras et al.
Wound complications The prevalence of wound complications was not significantly significant; nine studies saw a pooled estimated SMD of 0.49 (95% CI 0.22, 1.10; P = 0.08) (Figure 7 ).
The analysis may be underpowered to confirm smaller but clinically meaningful differences, particularly for the LBR, where a borderline non-significant trend (p=0.08) was observed.
According to the Cochrane analysis, “all studies showed a trend towards a better amputation-free salvage in the SCS group” as low as p=0.08 in the Spincemaille et al. study [ 25 , 27 ].
Regarding pathogen type, gram-negative infections showed a trend towards lower mortality (OR 0.53, 95% CI 0.27-1.04, p=0.08), though not statistically significant.
However, UACR showed a borderline significant effect (p = 0.080).
There was a marginally significant difference in perceptions of barriers (p=0.08), with males perceiving slightly more barriers than females.
While 90-day mortality showed a trend toward higher rates in transfused patients (2.4%, n=41 vs 0.5%, n=354), this difference did not reach statistical significance (p=0.08).
Reduced prevalence of dementia showed a trend toward independent association with the use of warfarin when an exploratory logistic regression was done (p=0.08) [ 24 ].
68.9%), but this relationship was marginally non-significant (χ2 = 3.08, df = 1, p = 0.08).
Higher-income remained significantly associated with greater risk in the multivariable model when accounting for other factors such as medical comorbidities (adjusted OR 1.35, 95% CI 1.25-1.46, P < 0.001), whereas white race was borderline significant when other factors were accounted for (adjusted OR 3.88, 95% CI 1.06-25.33, P = 0.08).
Second, a main effect test of the time factor (pre- and post-tests) at each level of the provision condition factor (F2F-PT and ON-PT) showed a marginal significance for F2F-PT ( F (1, 12) = 3.616; p = 0.081) and a significant difference for ON-PT ( F (1, 26) = 10.381; p = 0.003).
Notably, another study showing that there was no significant change in the Unified Parkinson Disease Rating Scale (UPDRS) score with caffeine found that the activities of daily living (ADL) associated with the disease score did almost significantly improve (p=0.081) [ 57 ], as shown in Table 2 .